Cite Filings / STOK / 0000932471-24-000715
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G/A

Amended Statement of Ownership

Stoke Therapeutics, Inc. · Filed 2024-11-04 · Acc 0000932471-24-000715

Documents 1

  • SC 13G/A Amended Statement of Ownership , UnitedStates_13G__StokeThera.txt

Around this filing

  • 2024-11-12 SC 13G/A Amended Statement of Ownership
  • 2024-11-05 4 CHIEF MEDICAL OFFICER sold 10,000 shares at $12.68 ($126,803)
  • 2024-11-05 10-Q Quarterly Report
  • 2024-11-05 8-K Results of operations
  • 2024-11-04 SC 13G/A Amended Statement of Ownership
  • 2024-11-01 144 Sale of Securities
  • 2024-02-26 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · RTW Investments, LP 9.9%
  2. 2026-11-16 SCHEDULE 13G/A · Baker Bros. Advisors LP 4.7%
  3. 2026-11-16 SCHEDULE 13G/A · Wellington Management Group LLP 7.3%
  4. 2026-11-13 SCHEDULE 13G/A · Morgan Stanley 4.9%
  5. 2026-08-12 SCHEDULE 13G/A · The Toronto-Dominion Bank 4.9%
  6. 2026-05-15 SCHEDULE 13G/A · The Toronto-Dominion Bank 5.4%
Loading UnitedStates_13G__StokeThera.txt…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…